BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 19427839)

  • 1. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors.
    Dogrul A; Ossipov MH; Porreca F
    Brain Res; 2009 Jul; 1280():52-9. PubMed ID: 19427839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways.
    Yanarates O; Dogrul A; Yildirim V; Sahin A; Sizlan A; Seyrek M; Akgül O; Kozak O; Kurt E; Aypar U
    Anesthesiology; 2010 Mar; 112(3):696-710. PubMed ID: 20179508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT₇ receptors.
    Dogrul A; Seyrek M; Akgul EO; Cayci T; Kahraman S; Bolay H
    Eur J Pharmacol; 2012 Feb; 677(1-3):93-101. PubMed ID: 22206817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal nefopam-induced antinociception through activation of descending serotonergic projections involving spinal 5-HT7 but not 5-HT3 receptors.
    Lee HG; Kim WM; Kim JM; Bae HB; Choi JI
    Neurosci Lett; 2015 Feb; 587():120-5. PubMed ID: 25534502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic cannabinoids produce CB₁-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors.
    Seyrek M; Kahraman S; Deveci MS; Yesilyurt O; Dogrul A
    Eur J Pharmacol; 2010 Dec; 649(1-3):183-94. PubMed ID: 20868676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord.
    Dogrul A; Seyrek M
    Br J Pharmacol; 2006 Nov; 149(5):498-505. PubMed ID: 16921395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury.
    Oatway MA; Chen Y; Weaver LC
    Pain; 2004 Jul; 110(1-2):259-68. PubMed ID: 15275776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance.
    Xie JY; Herman DS; Stiller CO; Gardell LR; Ossipov MH; Lai J; Porreca F; Vanderah TW
    J Neurosci; 2005 Jan; 25(2):409-16. PubMed ID: 15647484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive.
    Buhler AV; Choi J; Proudfit HK; Gebhart GF
    Pain; 2005 Mar; 114(1-2):285-94. PubMed ID: 15733655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury.
    Suzuki R; Rahman W; Hunt SP; Dickenson AH
    Brain Res; 2004 Sep; 1019(1-2):68-76. PubMed ID: 15306240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subset of μ-opioid receptor-expressing cells in the rostral ventromedial medulla contribute to thermal hyperalgesia in experimental neuropathic pain.
    Mase H; Sakai A; Sakamoto A; Suzuki H
    Neurosci Res; 2011 May; 70(1):35-43. PubMed ID: 21238509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary mechanical allodynia and hyperalgesia depend on descending facilitation mediated by spinal 5-HT₄, 5-HT₆ and 5-HT₇ receptors.
    Godínez-Chaparro B; López-Santillán FJ; Orduña P; Granados-Soto V
    Neuroscience; 2012 Oct; 222():379-91. PubMed ID: 22796074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E₂ in the spinal cord.
    Marshall TM; Herman DS; Largent-Milnes TM; Badghisi H; Zuber K; Holt SC; Lai J; Porreca F; Vanderah TW
    Pain; 2012 Jan; 153(1):86-94. PubMed ID: 22030324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat.
    Kovelowski CJ; Ossipov MH; Sun H; Lai J; Malan TP; Porreca F
    Pain; 2000 Sep; 87(3):265-273. PubMed ID: 10963906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal cord mechanisms mediating behavioral hyperalgesia induced by neurokinin-1 tachykinin receptor activation in the rostral ventromedial medulla.
    Lagraize SC; Guo W; Yang K; Wei F; Ren K; Dubner R
    Neuroscience; 2010 Dec; 171(4):1341-56. PubMed ID: 20888891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 in the midbrain periaqueductal gray produces hyperalgesia and activates pain-modulating circuitry in the rostral ventromedial medulla.
    Heinricher MM; Martenson ME; Neubert MJ
    Pain; 2004 Jul; 110(1-2):419-26. PubMed ID: 15275794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between metoclopramide and morphine: enhanced antinociception and motor dysfunction in rats.
    Kamerman PR; Becker N; Fick LG
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):106-12. PubMed ID: 17201744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral nerve injury reduces analgesic effects of systemic morphine via spinal 5-hydroxytryptamine 3 receptors.
    Kimura M; Obata H; Saito S
    Anesthesiology; 2014 Aug; 121(2):362-71. PubMed ID: 24887968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of 5-HT7 receptors reduces tactile allodynia in the rat.
    Amaya-Castellanos E; Pineda-Farias JB; Castañeda-Corral G; Vidal-Cantú GC; Murbartián J; Rocha-González HI; Granados-Soto V
    Pharmacol Biochem Behav; 2011 Oct; 99(4):591-7. PubMed ID: 21693130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Descending serotonergic facilitation mediated through rat spinal 5HT3 receptors is unaltered following carrageenan inflammation.
    Rahman W; Suzuki R; Rygh LJ; Dickenson AH
    Neurosci Lett; 2004 May; 361(1-3):229-31. PubMed ID: 15135935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.